Clinical Trials Directory

Trials / Unknown

UnknownNCT06027047

Breakthrough Anxiety and Sleep Evaluation Using Linked Devices and Smartphone Application Onar (BASEL)

Status
Unknown
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Raivotech · Industry
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

Sleep is not simply the absence of wakefulness. Sleep is an active procedure, normally happening every night, and is absolutely vital. Good sleep is essential for our well-being. Survival without food can be further than without sleep. Work time and commuting time seem to affect total sleep time and night bedtime. Social and work obligation can, therefore, suppress sleep time. Sleep deprived individuals may be facing anxiety and depression symptoms. The aim of this study is to investigate the presence of anxiety and depression symptoms among adults with the use of the smartphone application Onar. Onar app will be used to gather information from wearable devices of the users including total sleep time, sleep efficiency, wake after sleep onset time. An established questionnaire (Hospital Anxiety Depression Scale/ HADS) will be used to quantify and detect the presence of anxiety and depression in the study population.

Conditions

Timeline

Start date
2023-09-01
Primary completion
2023-12-31
Completion
2024-01-15
First posted
2023-09-07
Last updated
2023-09-07

Source: ClinicalTrials.gov record NCT06027047. Inclusion in this directory is not an endorsement.

Breakthrough Anxiety and Sleep Evaluation Using Linked Devices and Smartphone Application Onar (BASEL) (NCT06027047) · Clinical Trials Directory